| The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. | |
| | |
MedLine Citation:
|
PMID: 21144444 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Venice 2 human papillomavirus vaccination survey evaluates the state of introduction of the HPV vaccination into the national immunisation schedules in the 29 participating countries. As of July 2010, 18 countries have integrated this vaccination. The vaccination policy and achievements vary among those countries regarding target age groups, delivery infrastructures and vaccination coverage reached. Financial constraints remain the major obstacle for the 11 countries who have not yet introduced the vaccination. |
| | |
Authors:
|
F Dorleans; C Giambi; L Dematte; S Cotter; P Stefanoff; J Mereckiene; D O'Flanagan; P L Lopalco; F D'Ancona; D Levy-Bruhl; |
Related Documents
:
|
23386724 - Langerin negative dendritic cells promote potent cd8+ t-cell priming by skin delivery o... 23414404 - Developments in virus-like particle-based vaccines for hiv. 22206254 - Knowing is half the battle: targeting virulence factors of group a streptococcus for va... 3124494 - The maxillary sinus in the higher primates. 4635394 - Responses of previously reinfected rubella vaccinees to challenge with brown strain rub... 12519624 - Interventions aimed at improving immunization rates. |
Publication Detail:
|
Type: Evaluation Studies; Journal Article Date: 2010-11-25 |
Journal Detail:
|
Title: Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin Volume: 15 ISSN: 1560-7917 ISO Abbreviation: Euro Surveill. Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2010-12-14 Completed Date: 2011-03-04 Revised Date: 2013-05-01 |
Medline Journal Info:
|
Nlm Unique ID: 100887452 Medline TA: Euro Surveill Country: Sweden |
Other Details:
|
Languages: eng Pagination: - Citation Subset: IM |
Affiliation:
|
Department of Infectious Diseases, Institut de Veille Sanitaire (InVS, French Institute for Public Health Surveillance), Paris, France. f.dorleans@invs.sante.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Child Decision Making Europe Female Health Policy Health Surveys Humans Immunization Programs / organization & administration*, trends Immunization Schedule Mass Vaccination / economics, statistics & numerical data*, trends Papillomavirus Infections / immunology, prevention & control* Papillomavirus Vaccines / administration & dosage*, economics Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Papillomavirus Vaccines |
| Investigator | |
Investigator/Affiliation:
|
Francoise Berthet / ; Charmaine Gauci / ; Suzanne Cotter / ; Paolo Fortunato D'Ancona / ; Hester de Melker / ; Berit Feiring / ; Teresa Fernandes / ; Steffen Glismann / ; Chicin Gratiana / ; Thorulf Gudnason / ; Helena Hudecova / ; Natalia Kerbo / ; Jean-Paul Klein / ; Mira Kojouharova / ; Alenka Kraigher / ; Bohumir Kriz / ; Tuija Leino / ; Daniel Levy Bruhl / ; Annika Linde / ; Zsuzsanna Molnar / ; Richard Pebody / ; Isabel Pena Rey / ; Jurijs Perevoscikovs / ; Sabine Reiter / ; Soteroulla Soteriou / ; Theodora Stavrou / ; Pawel Stefanoff / ; Egle Valikoniene / ; Pierre Van Damme / |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Type 1 wild poliovirus and putative enterovirus 109 in an outbreak of acute flaccid paralysis in Con...
Next Document: Clinical laboratory practices for detection and reporting of Cryptosporidium in community cases of d...